EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetic study of enteric capsule-based mini-tablets of duloxetine and mirtazapine by LC-MS/MS

BVVSN Prasad, Mithun Rudrapal, AT Bapuji

Acta Chromatographica · 28.07.2026

DOI: 10.1556/1326.2026.01502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Chromatographica, erschienen am 28.07.2026. Verfasst von BVVSN Prasad und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aimed to develop and evaluate an enteric capsule-based mini-tablet system (ECDDS) for duloxetine and mirtazapine, focusing on regulated intestinal release and improved pharmacokinetic performance. Duloxetine and mirtazapine, in optimized mini-tablet form, were encapsulated in enteric-coated capsules. In vivo X-ray imaging of rabbits with BaSO 4 -labeled capsules showed how capsules move through the digestive system and confirmed that the capsules released their contents in the intestine. A validated LC-MS/MS method was employed to measure plasma concentrations in compliance with US-FDA bioanalytical standards. Non-compartmental analysis was utilized to calculate pharmacokinetic parameters. X-ray imaging showed that the ECDDS resided in the stomach for more than 2 h and then dissolved in the small intestine in 3–5 h. Optimized formulations exhibited delayed T max and prolonged half-life compared to drug solution (duloxetine: T max 8.0 h vs. 5.0 hr; t ½ 16.56 vs. 9.83 hr; mirtazapine: T max 5.0 vs. 1.5 h; t ½ 40.23 vs. 26.32 h) with enhanced AUC (0–∞) , indicating improved bioavailability. The developed ECDDS achieved site-specific release, sustained plasma exposure, and superior pharmacokinetic performance, thus suggesting its potential to enhance efficacy and compliance in combination antidepressant therapy.

Zitieren

APA

Prasad, B., Rudrapal, M., & Bapuji, A. (2026). Pharmacokinetic study of enteric capsule-based mini-tablets of duloxetine and mirtazapine by LC-MS/MS. Acta Chromatographica. https://doi.org/10.1556/1326.2026.01502

Vancouver

Prasad B, Rudrapal M, Bapuji A. Pharmacokinetic study of enteric capsule-based mini-tablets of duloxetine and mirtazapine by LC-MS/MS. Acta Chromatographica. 2026. doi:10.1556/1326.2026.01502

BibTeX
@article{Prasad2026,
  author = {Prasad, BVVSN and Rudrapal, Mithun and Bapuji, AT},
  title = {Pharmacokinetic study of enteric capsule-based mini-tablets of duloxetine and mirtazapine by LC-MS/MS},
  journal = {Acta Chromatographica},
  year = {2026},
  doi = {10.1556/1326.2026.01502}
}
Kostenlos starten →